DelveInsight has launched a new report on “Presbyopia – Market Insights, Epidemiology, and Market Forecast-2032”.
Some of the key facts of the Presbyopia Market Report:
In the year 2020, the total prevalent cases of Presbyopia were 134,726,460 cases in EU-5 which are expected to grow during the study period, i.e., 2019–2032.
In Japan, the total number of prevalent cases of Presbyopia was 34,897,947 cases in the year 2020 which are expected to grow during the study period, i.e., 2019–2032.
As per DelveInsight’s analysts, in 2020 Japan accounts for 11,981,628 and 17,972,442 of male and female cases respectively of Presbyopia in the 7MM population.
Key benefits of the report:
Presbyopia market report covers a descriptive overview and comprehensive insight of the Presbyopia Epidemiology and Presbyopia market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
The Presbyopia market report provides insights on the current and emerging therapies.
Presbyopia market report provides a global historical and forecasted market covering drug outreach in 7MM.
The Presbyopia market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Presbyopia market.
Presbyopia is defined as the gradual loss of near-focusing ability that occurs with age. Most people begin to notice the effects of presbyopia sometime after age 40. This typically comes on between the ages of 40 and 60 as the lenses of the eyes naturally lose elasticity due to the aging process.
Presbyopia can be classified by type which includes incipient presbyopia, functional presbyopia, absolute presbyopia, premature presbyopia, and nocturnal presbyopia. Presbyopia can be said to be caused partly due to age-related changes in the proteins within the lens of the eye due to which, it becomes thicker, harder, and less flexible. This loss of flexibility affects the lens’s ability to refract light rays which, in turn, affects the eye’s capacity to focus.
The dynamics of the Presbyopia market are anticipated to change in the coming years owing to the expected launch of emerging therapies by companies such as Allergan (AbbVie), Eyenovia, Orasis Pharmaceuticals, Novartis, Ocuphire Pharma, Visus Therapeutics, and others during the study period 2019-2032.
Request for a free sample report @ Presbyopia Market Scenario
Presbyopia Pipeline Therapies and Key Companies
AGN-190584: Allergan (acquired by AbbVie)
MicroLine (Pilocarpine Ophthalmic): Eyenovia
PresbiDrops (CSF-1): Orasis Pharmaceuticals
UNR844 (Lipoic acid choline ester): Novartis
Nyxol (Phentolamine Mesylate): Ocuphire Pharma
VTI-001 (Brimochol): Visus Therapeutics
AGN-241622: Allergan (acquired by AbbVie)
Presbyopia Market Drivers
Increase in the geriatric population
Increasing research in pharmaceutical treatment
An upsurge in the launch of products
Table of Contents
1. Report Introduction
2. Executive Summary
3. SWOT analysis
4. Presbyopia Patient Share (%) Overview at a Glance
5. Presbyopia Market Overview at a Glance
6. Presbyopia Disease Background and Overview
7. Presbyopia Epidemiology and Patient Population
8. Country-Specific Patient Population of Presbyopia
9. Presbyopia Current Treatment and Medical Practices
10. Unmet Needs
11. Presbyopia Emerging Therapies
12. Presbyopia Market Outlook
13. Country-Wise Presbyopia Market Analysis (2019-2032)
14. Market Access and Reimbursement of Therapies
15. Market drivers
16. Market barriers
18. Presbyopia Report Methodology
19. DelveInsight Capabilities
21. About DelveInsight
Click here to read more about Presbyopia Market Outlook 2032.
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Address:304 S. Jones Blvd #2432
City: Las Vegas
Country: United States